Learn More
Medchemexpress LLC Oxidopamine (hydrobromide) | 636-00-0 | 99.4% | 500 MG

Supplier: Medchemexpress LLC HYB1081A500MG
Oxidopamine (6-OHDA) hydrobromide is a potent neurotoxin that selectively destroys dopaminergic neurons by acting as an antagonist of the neurotransmitter dopamine. It is a valuable tool for research into various neurological conditions, including Parkinson's disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome. The compound also promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion.
- Selectively destroys dopaminergic neurons
- Antagonist of dopamine neurotransmitter
- Promotes COX-2 activation and PGE2 synthesis
- Induces pro-inflammatory cytokine IL-1β secretion
- Useful for Parkinson's disease research models
- Applicable in ADHD and Lesch-Nyhan syndrome studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.